Physician profile
Brittany Wright
NPI 1497181333
$531.07
in general payments reported to CMS, 2019-2025
15 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $88.14 · 2022: $134 · 2023: $77.18 · 2024: $81.96 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $308.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $74.41 | 2021-2025 | |
| Novo Nordisk INC | $61.44 | 2021-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $53.19 | 2022-2025 | Shingrix, Arexvy, Pediarix |
| Exact Sciences Corporation | $49.39 | 2023-2025 | Cologuard Collection Kit |
| Dexcom, INC. | $43.07 | 2021-2022 | |
| Lilly USA, LLC | $39.08 | 2022-2025 | Zepbound |
| Abbott Laboratories | $37.49 | 2022-2025 | Freestyle Libre |
| Hologic Sales and Service, LLC | $32.28 | 2024 | Thinprep 2000 Processor, Aptima, Third Wave |
| Astrazeneca Pharmaceuticals Lp | $30.88 | 2023-2024 | Airsupra, Farxiga |
| Boston Scientific Corporation | $27.30 | 2022 | |
| Amgen INC. | $18.53 | 2024 | Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.59 | 2021 | |
| Axsome Therapeutics, INC. | $17.31 | 2022 | |
| Janssen Pharmaceuticals, INC | $16.62 | 2025 | Spravato |
| Biohaven Pharmaceuticals, INC. | $12.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.